In cancer immunotherapy, gut microbiota enhanced cancer response to the combination of CpG and anti-IL-10R through increasing tumor necrosis factor (TNF) production, which depends on the activation of TLR4 on tumor amyloid cells. Here, IL10RA is linked to cancer.